[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "T-cell therapy",
            "immunotherapy",
            "adoptive cellular therapy",
            "T-Cell Receptor",
            "IMA201",
            "Cytotherapy",
            "Cell Therapy",
            "Gene Therapy"
        ],
        "dcp_id": null,
        "interventional_model": "Single Group",
        "lead_org": "Immatics US, Inc.",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Patient \u2265 18 years of age"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Pathologically confirmed advanced and/or metastatic solid tumor"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Patients may enter screening procedure before, during, or after the last available indicated standard of care treatment. There is no limitation for prior anti cancer treatments."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Eastern Cooperative Oncology Group (ECOG) performance status 0-1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "HLA phenotype positive for the study"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Patients must have measurable disease according to RECIST 1.1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Disease accessible to biopsy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Adequate pulmonary function per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Adequate organ and bone marrow function per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Acceptable coagulation status per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Adequate hepatic function per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "Adequate renal function per protocol"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "Patient's tumor must express tumor antigen by qPCR using a fresh tumor biopsy specimen"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Life expectancy more than 3 months"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "Confirmed availability of production capacities for IMA201 product"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 15,
                    "description": "Patients must have recurrent/progressing and/or refractory solid tumors and must have received or not be eligible for all available indicated standard of care treatment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 16,
                    "description": "For hepatocellular carcinoma (HCC) patients only, Child-Pugh score of \u2264 6"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 17,
                    "description": "IMA201 product must have passed all of the release tests"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 18,
                    "description": "Female patient of childbearing potential must use adequate contraception prior to study entry until 12 months after the infusion of IMA201"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 19,
                    "description": "Male patient must agree to use effective contraception or be abstinent while on study and for 6 months after the infusion of IMA201"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 20,
                    "description": "The patient must have recovered from any side effects of prior therapy to Grade 1 or lower (except for non-clinically significant toxicities; e.g., alopecia, vitiligo) prior to lymphodepletion. As determined by the investigator, the patient may still be eligible if the patient has not fully recovered from Grade \u2265 2 toxicities if these toxicities are not anticipated to further improve (e.g., chronic neuropathy) and such toxicities are not anticipated to worsen with the lymphodepletion therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "History of other malignancies (except for adequately treated basal or squamous cell carcinoma or carcinoma in situ) within the last 3 years"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "Solid tumors with low likelihood of tumor biomarker expression per protocol"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Pregnant or breastfeeding"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "Serious autoimmune disease Note: At the discretion of the investigator, these patients may be included if their disease is well controlled without the use of immunosuppressive agents."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "History of cardiac conditions as per protocol"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "Prior stem cell transplantation or solid organ transplantation"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "Concurrent severe and/or uncontrolled medical disease that could compromise participation in the study"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "History of hypersensitivity to cyclophosphamide (CY), fludarabine (FLU), or IL-2, or to any of the rescue medications"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 29,
                    "description": "History of or current immunodeficiency disease or prior treatment compromising immune function at the discretion of the treating physician"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 30,
                    "description": "HIV infection, active hepatitis B virus (HBV), active hepatitis C virus (HCV) infection, ongoing active anti-HCV treatment or detectable HBV or HCV viral load at the most recent laboratory report. Patients with both HBV and HCV infections will be excluded from screening"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 31,
                    "description": "Patients with a history of HCV infection and with an undetectable viral load per the most recent laboratory report and/or completed anti-HCV treatment but are HCV antibody positive are permitted."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 32,
                    "description": "History of treated HBV infection is permitted if the viral load is undetectable per the most recent laboratory report. Note: HCC patients with controlled HBV infection, as defined by resolved (anti-hepatitis B surface antigen [HBs-Ag] antibody (Ab) negative, anti-core antigen [HBc Ag] Ab positive) or chronic stable (anti HBs-Ag Ab positive) HBV infection will be eligible for screening. Patients with active HBV infection who are not on anti-HBV treatment will be excluded."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 33,
                    "description": "Any condition contraindicating leukapheresis, lymphodepletion, low-dose IL-2, and/or IMA201 treatment"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 34,
                    "description": "Patients with any active viral infection"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 35,
                    "description": "Patients with active brain metastases NOTE: Patients with a history of brain metastases may be eligible, if an imaging scan with contrast enhancement not older than 4 weeks is able to exclude the existence of currently active brain metastasis, and steroid therapy has been discontinued for \u22652 weeks."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 36,
                    "description": "Treatment with protocol-defined excluded treatments, medical devices, and/or procedures per protocol"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 37,
                    "description": "Concurrent participation in an interventional part of another clinical trial"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "SCREENING: Patient eligibility will be determined by HLA (human leukocyte antigen) screening\r\n      and the biomarkers screening. If the patient is eligible, white blood cells will be taken\r\n      during leukapheresis for the manufacture of the IMA201 product.\r\n\r\n      MANUFACTURING: IMA201 product will be made from the patient's white blood cells.\r\n\r\n      TREATMENT: Lymphodepletion with cyclophosphamide and fludarabine will occur in the days\r\n      before the IMA201 infusion to improve the duration of time that IMA201 stays in the body.\r\n\r\n      After IMA201 infusion, a low dose of IL-2 will be given twice daily for a period of time.\r\n\r\n      Patients will be closely monitored for safety and for a total of 3 years post IMA201\r\n      infusion.",
        "official_title": "Phase 1 Study Evaluating Genetically Modified Autologous T Cells Expressing a T-cell Receptor Recognizing a Cancer/Germline Antigen in Patients With Recurrent and/or Refractory Solid Tumors (ACTengine\u00ae IMA201-101)",
        "_phase_sort_order": 4,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "until 21 days post treatment",
                "name": "Determination of the maximum tolerated dose (MTD)",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "up to 3 years post-treatment",
                "name": "Duration of infused T cells over time (Persistence of T cells)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "up to 3 years post-treatment",
                "name": "Incidence of adverse events (AE)",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "up to 12 months",
                "name": "Tumor response per Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 and immune-related RECIST (irRECIST)",
                "description": null,
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 1,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03247309",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Class I MHC",
                    "MHC Class I"
                ],
                "nci_thesaurus_concept_id": "C16617",
                "name": "MHC Class I Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16812",
                    "C16612",
                    "C25790"
                ],
                "parents": [
                    "C16812"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Expressed",
                    "Expression Detected"
                ],
                "nci_thesaurus_concept_id": "C177692",
                "name": "Expression Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C36292"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25790",
                "name": "Immunoprotein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "HLA-A*0201 Positive",
                    "HLA-A*02:01 Positive Cells Present"
                ],
                "nci_thesaurus_concept_id": "C69178",
                "name": "HLA-A*0201 Positive Cells Present",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C25790",
                    "C3367",
                    "C28585",
                    "C16812",
                    "C69408",
                    "C35682",
                    "C36292",
                    "C16617",
                    "C16612",
                    "C129450",
                    "C77140",
                    "C177692"
                ],
                "parents": [
                    "C129450",
                    "C28585",
                    "C69408"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HLA-A*02 Positive",
                    "HLA-A*02 Positive Cells Present",
                    "HLA-A*2 Positive",
                    "HLA-A02 Allele Positive",
                    "HLA-A02 Positive",
                    "HLA-A2 Positive"
                ],
                "nci_thesaurus_concept_id": "C69408",
                "name": "HLA-A2 Positive Cells Present",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C28585",
                    "C16612",
                    "C36292",
                    "C25790",
                    "C16812",
                    "C16617",
                    "C77140",
                    "C3367",
                    "C35682",
                    "C177692"
                ],
                "parents": [
                    "C177692",
                    "C28585"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HLA Complex Gene"
                ],
                "nci_thesaurus_concept_id": "C16812",
                "name": "Major Histocompatibility Complex Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612",
                    "C25790"
                ],
                "parents": [
                    "C25790"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HLA-A*0201 Positive"
                ],
                "nci_thesaurus_concept_id": "C129450",
                "name": "HLA Class I Histocompatibility Antigen, A-0201 Alpha Chain Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C25790",
                    "C3367",
                    "C28585",
                    "C16812",
                    "C16617",
                    "C35682",
                    "C36292",
                    "C16612",
                    "C77140",
                    "C177692"
                ],
                "parents": [
                    "C177692",
                    "C28585"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Lab Value",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HLA-A",
                    "Major Histocompatibility Complex, Class I, A Gene"
                ],
                "nci_thesaurus_concept_id": "C28585",
                "name": "HLA-A Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C16812",
                    "C16612",
                    "C25790",
                    "C16617"
                ],
                "parents": [
                    "C16617"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2023-02-03",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Solid Tumor",
                    "Relapsed Malignant Solid Neoplasm",
                    "Recurrent Malignant Solid Neoplasm",
                    "Relapsed Solid Neoplasm",
                    "Relapsed Solid Tumor",
                    "Recurrent Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127153",
                "name": "Recurrent Malignant Solid Tumor",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C132146",
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Malignant Solid Neoplasm",
                    "Metastatic Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Solid Tumor",
                    "Advanced Solid Neoplasm",
                    "Advanced Non-Hematologic Malignancy",
                    "Advanced Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C129707",
                "name": "Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9270",
                    "C127155"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133737",
                "name": "Refractory Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C132146",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Neoplasm",
                    "Solid Tumour",
                    "Solid tumor, NOS"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Cancer",
                    "resistant cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4798",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm Recurrence",
                    "Recurrence",
                    "Recurrent Tumor",
                    "Recurrent"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "IMA201-101",
        "active_sites_count": 3,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Cyclostine",
                            "Fosfaseron",
                            "Cycloblastin",
                            "CYCLO-cell",
                            "Cycloblastine",
                            "Cyclostin",
                            "Ledoxina",
                            "Carloxan",
                            "Genoxal",
                            "Cicloxal",
                            "Cytophosphan",
                            "Genuxal"
                        ],
                        "nci_thesaurus_concept_id": "C405",
                        "name": "Cyclophosphamide",
                        "description": "A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C697",
                            "C574"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Cell-based Gene Therapy Agent",
                            "Genetically-altered Immune Cell",
                            "Genetically-modified Immune Cell"
                        ],
                        "nci_thesaurus_concept_id": "C154231",
                        "name": "Genetically-engineered Immune Cell",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1962",
                            "C142078"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapy Alkylating Agents",
                            "Chemotherapy Alkylators"
                        ],
                        "nci_thesaurus_concept_id": "C1590",
                        "name": "Antineoplastic Alkylating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2842"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Cytokines"
                        ],
                        "nci_thesaurus_concept_id": "C1283",
                        "name": "Recombinant Cytokine",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C64263",
                        "name": "Laboratory Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C74957",
                            "C63333"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Interleukins"
                        ],
                        "nci_thesaurus_concept_id": "C593",
                        "name": "Recombinant Interleukin",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1283"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C63333",
                        "name": "Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Tumor Agents",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C74957",
                        "name": "Mixed Category Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25294"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C64900",
                        "name": "Diagnostic Laboratory Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C64263"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C697",
                        "name": "Nitrogen Mustard Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2114"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Tumor Agents",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunopotentiators",
                            "Immune Mediators",
                            "Immunomodulating Agent",
                            "BRM",
                            "Biomodulators",
                            "Biological Response Modifier",
                            "Immunomodulators",
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Immunomodulatory Agent",
                            "Immunotherapeutic Agent",
                            "Immune Regulators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antimetabolites"
                        ],
                        "nci_thesaurus_concept_id": "C272",
                        "name": "Antimetabolite",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C186664"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Biological Agent",
                            "Anticancer Biological",
                            "Antineoplastic Biotherapeutic",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologics",
                            "Biologics",
                            "Biological Products",
                            "Biopharmaceuticals",
                            "Biologicals",
                            "Immunologic, Immunochemical"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Autologous T-cells"
                        ],
                        "nci_thesaurus_concept_id": "C28681",
                        "name": "Therapeutic Autologous Lymphocytes",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C142078"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Interleukin-2",
                            "Mitogenic Factor",
                            "Interleukin II",
                            "Lymphocyte Mitogenic Factor",
                            "Thymocyte Stimulating Factor",
                            "T-Cell Growth Factor"
                        ],
                        "nci_thesaurus_concept_id": "C587",
                        "name": "Recombinant Interleukin-2",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C593"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Immune Cells",
                            "Anti-cancer Immune Cell"
                        ],
                        "nci_thesaurus_concept_id": "C129826",
                        "name": "Antineoplastic Immune Cell",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C142078",
                            "C129821",
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Cytotoxic Agent",
                            "Cytotoxic Chemotherapy Agent",
                            "Cytotoxic Antineoplastic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C186664",
                        "name": "Cytotoxic Chemotherapeutic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Procedure",
                            "Intervention",
                            "Intervention Strategies"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biological Response Modifier",
                            "Antineoplastic Immunotherapeutic",
                            "Antineoplastic BRM",
                            "Anti-cancer Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacologic Agent",
                            "Drug Substance",
                            "Pharmaceuticals",
                            "Pharmaceutical Agent",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Inhibitor Drug",
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunosuppressive Agents"
                        ],
                        "nci_thesaurus_concept_id": "C574",
                        "name": "Immunosuppressant",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacologic Agent",
                            "Drug Substance",
                            "Pharmaceuticals",
                            "Pharmaceutical Agent",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Proleukin"
                        ],
                        "nci_thesaurus_concept_id": "C1498",
                        "name": "Aldesleukin",
                        "description": "A recombinant analog of the endogenous cytokine interleukin-2 (IL-2) with immunoregulatory and antineoplastic activities. Aldesleukin binds to and activates the IL-2 receptor, followed by heterodimerization of the cytoplasmic domains of the IL-2R beta and gamma(c) chains; activation of the tyrosine kinase Jak3; and phosphorylation of tyrosine residues on the IL-2R beta chain, resulting in an activated receptor complex. Various cytoplasmic signaling molecules are recruited to the activated receptor complex and become substrates for regulatory enzymes that are associated with the receptor complex. This agent enhances lymphocyte mitogenesis; stimulates long-term growth of human IL-2 dependent cell lines; enhances lymphocyte cytotoxicity; induces lymphokine-activated killer (LAK) cell and natural killer (NK) cell activities; and induces expression of interferon-gamma. Aldesleukin may induce T cell-mediated tumor regression in some tumor types. Check for active clinical trials or closed cli",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C587"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2842",
                        "name": "DNA Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C186664"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Purine Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C1556",
                        "name": "Purine Antagonist",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C272"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Laboratory Test",
                            "Tests",
                            "Lab Tests",
                            "Test",
                            "Lab Test"
                        ],
                        "nci_thesaurus_concept_id": "C25294",
                        "name": "Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2114",
                        "name": "Mustard Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1590"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C146779",
                        "name": "Autologous TCR-engineered T-cells IMA201",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C28681",
                            "C129826",
                            "C138180"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1094",
                        "name": "Fludarabine",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1556",
                            "C2150"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "TCR-engineered T-cells",
                            "TCR T-cells",
                            "TCR-modified T Cells",
                            "T-cell Receptor-engineered T Cells",
                            "TCR T Cells",
                            "T-cell Receptor-engineered T-lymphocytes"
                        ],
                        "nci_thesaurus_concept_id": "C138180",
                        "name": "T-cell Receptor-engineered T-cells",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C154231"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2150",
                        "name": "Ribonucleotide Reductase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Adoptive Cell-based Agent",
                            "ACT Agent",
                            "Adoptive Cell Therapy Agent",
                            "Adoptive Cell Transfer Agent",
                            "Adoptive Cellular Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C142078",
                        "name": "Adoptive Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunopotentiators",
                            "Immune Mediators",
                            "Immunomodulating Agent",
                            "BRM",
                            "Biomodulators",
                            "Biological Response Modifier",
                            "Immunomodulators",
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Immunomodulatory Agent",
                            "Immunotherapeutic Agent",
                            "Immune Regulators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Gene Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1962",
                        "name": "Gene Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "IMA201 Product",
                "description": "Pre-conditioning by non-myeloablative chemotherapy with Fludarabine and Cyclophosphamide\r\nOne dose of IMA201 product will be infused intravenously. Up to four dose levels will be evaluated. At least two patients per cohort will be treated.\r\nPost-infusion of IMA201 product, administration of low-dose recombinant human interleukin-2",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2018-00208",
        "why_study_stopped": null,
        "brief_summary": "The study purpose is to establish the safety and tolerability of IMA201 in patients with\r\n      solid tumors that express melanoma-associated antigen 4 and/or 8 (MAGEA4/8).",
        "brief_title": "TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)",
        "status_history": [
            {
                "status_date": "2023-02-03T00:00:00.000001",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2017-09-26T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 22,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 7,
        "start_date": "2018-12-19",
        "record_verification_date": "2023-02-01",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "NA"
        },
        "acronym": "ACTengine",
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2024-12-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]